Skip to main content
CQ

Chiral Quest

The company supplies a catalog of over 1,000 enantiomerically pure chiral building blocks and offers contract custom asymmetric synthesis using proprietary catalysts. It delivers GMP‑compatible batches from milligram to kilogram scale with full analytical certification and regulatory documentation, enabling pharma, agrochemical and academic R&D teams to accelerate lead optimization without in‑house chiral chemistry.

Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Pharmaceutical and agrochemical research programs often require enantiomerically pure compounds, but sourcing high‑purity chiral building blocks and executing reliable asymmetric syntheses can be time‑consuming and technically demanding. Limited availability of specialized chiral intermediates slows drug discovery and crop‑protection development cycles.

Solution

The company provides a comprehensive catalog of commercially available chiral building blocks alongside contract custom synthesis services tailored to asymmetric routes. By leveraging proprietary chiral catalysts and optimized reaction conditions, they deliver enantiomerically pure intermediates with purity levels suitable for pre‑clinical and GMP manufacturing. Their integrated workflow includes rapid scale‑up, rigorous analytical verification, and regulatory documentation, enabling customers to accelerate lead optimization without investing in in‑house chiral chemistry expertise. Clients receive detailed batch records and can request iterative design modifications to align with evolving project needs.

Target Audience

Primary customers are pharmaceutical and agrochemical R&D teams, contract research organizations, and academic laboratories that require high‑purity enantiomers for lead generation and process development.

Features

  • Extensive library of >1,000 chiral building blocks covering amines, alcohols, acids, and heterocycles
  • Custom asymmetric synthesis using proprietary chiral catalysts and biocatalytic platforms
  • Scalable production from milligram to kilogram batches under GMP‑compatible conditions
  • Full analytical suite (chiral HPLC, SFC, NMR, MS) with certificates of analysis for each lot
  • Rapid turnaround options: standard (2‑3 weeks) and expedited (≤7 days) timelines
  • Integrated regulatory support, including impurity profiling and safety data sheets
  • API and LIMS integration for automated order placement and batch tracking
  • Secure, temperature‑controlled logistics for sensitive chiral compounds
This profile is AI-generated and may contain inaccuracies.